Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma

JAMA

Volumn 306, Issue 4, 2011, Pages 410-419

  Orloff, Mohammed ^a,b   Peterson, Charissa ^a   He, Xin ^a   Ganapathi, Shireen ^a   Heald, Brandie ^a,b   Yang, Yi Ran ^a   Bebek, Gurkan ^a,c   Romigh, Todd ^a   Song, Jee Hoon ^d   Wu, Wenjing ^d   David, Stefan ^d   Cheng, Yulan ^d   Meltzer, Stephen J ^d   Eng, Charis ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCND1 PROTEIN; MSR1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; ASCC1 GENE; BARRETT ESOPHAGUS; CANCER SUSCEPTIBILITY; CELL NUCLEUS; CELL STRAIN HEK293; CONTROLLED STUDY; CTHRC1 GENE; ESOPHAGEAL ADENOCARCINOMA; FUNCTIONAL GENOMICS; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GERMLINE MUTATION; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MSR1 GENE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SIBLING; UPREGULATION;

EID: 79960722980     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1029     Document Type: Article

References (53)

1. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83(10):2049-2053. (Pubitemid 28525384)
2. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am. 1997;26(3):487-494. (Pubitemid 27453229)
3. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199-211. (Pubitemid 41076753)
4. Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95(18):1404-1413. (Pubitemid 37220460)
5. Winters C Jr, Spurling TJ, Chobanian SJ, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987;92(1):118-124. (Pubitemid 17207669)
6. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825-1831. (Pubitemid 41772961)
7. Groopman JD, Kensler TW. Role of metabolism and viruses in aflatoxin-induced liver cancer. Toxicol Appl Pharmacol. 2005;206(2):131-137. (Pubitemid 40834307)
8. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med. 1986;315(6):362-371. (Pubitemid 16060091)
9. Murray L, Watson P, Johnston B, Sloan J, Mainie IM, Gavin A. Risk of adenocarcinoma in Barrett's oesophagus: population based study. BMJ. 2003;327(7414):534-535. (Pubitemid 37088499)
10. Drovdlic CM, Goddard KA, Chak A, et al. Demographic and phenotypic features of 70 families segregating Barrett's oesophagus and oesophageal adenocarcinoma. J Med Genet. 2003;40(9):651-656. (Pubitemid 37100696)
11. Fitzgerald RC. Complex diseases in gastroenterology and hepatology: GERD, Barrett's, and esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2005;3(6):529-537. (Pubitemid 40824745)
12. Chak A, Ochs-Balcom H, Falk G, et al. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1668-1673. (Pubitemid 44497103)
13. SAGE: Statistical Analysis for Genetic Epidemiology. Cork, Ireland: Statistical Solutions; 2003.
14. Goddard KA, Witte JS, Suarez BK, Catalona WJ, Olson JM. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet. 2001;68(5):1197-1206. (Pubitemid 32424418)
15. Haseman JK, Elston RC. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet. 1972;2(1):3-19.
16. Elston RC, Guo X, Williams LV. Two-stage global search designs for linkage analysis using pairs of affected relatives. Genet Epidemiol. 1996;13(6):535-558. (Pubitemid 26428248)
17. Guo X, Elston RC. Two-stage global search designs for linkage analysis I: use of the mean statistic for affected sib pairs. Genet Epidemiol. 2000;18(2):97-110. (Pubitemid 30100072)
18. Guo X, Elston RC. Two-stage global search designs for linkage analysis II: including discordant relative pairs in the study. Genet Epidemiol. 2000;18(2):111-127. (Pubitemid 30100073)
19. Ziegler A, Böddeker I, Geller F, Müller HH, Guo X. On the total expected study cost in two-stage genome-wide search designs for linkage analysis using themean test for affected sib pairs. Genet Epidemiol. 2001;20(3):397-400.
20. van Dekken H, Vissers K, Tilanus HW, et al. Genomic array and expression analysis of frequent high-level amplifications in adenocarcinomas of the gastroesophageal junction. Cancer Genet Cytogenet. 2006;166(2):157-162.
21. Reich D, Price AL, Patterson N. Principal component analysis of genetic data. Nat Genet. 2008;40(5):491-492. (Pubitemid 351601228)
22. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904-909. (Pubitemid 44141658)
23. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science. 1997;278(5343):1580-1581. (Pubitemid 27516268)
24. Morris RW, Kaplan NL. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol. 2002;23(3):221-233.
25. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered. 2002;53(2):79-91. (Pubitemid 34621657)
26. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575. (Pubitemid 47330214)
27. Stairs DB, Nakagawa H, Klein-Szanto A, et al. Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. PLoS One. 2008;3(10):e3534.
28. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998;95(25):14863-14868. (Pubitemid 29003722)
29. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11(3):241-247.
30. Xu J, Zheng SL, Komiya A, et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet. 2002;32(2):321-325.
31. Xu J, Zheng SL, Komiya A, et al. Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Am J Hum Genet. 2003;72(1):208-212. (Pubitemid 36056858)
32. Xu J, Sauvageot J, Ewing CM, et al. Germline ATBF1 mutations and prostate cancer risk. Prostate. 2006;66(10):1082-1085. (Pubitemid 43939212)
33. Emi M, Asaoka H, Matsumoto A, et al. Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J Biol Chem. 1993;268(3):2120-2125. (Pubitemid 23033622)
34. Maier C, Herkommer K, Hoegel J, Vogel W, Paiss T. A genomewide linkage analysis for prostate cancer susceptibility genes in families from Germany. Eur J Hum Genet. 2005;13(3):352-360. (Pubitemid 40360791)
35. Maier C, Vesovic Z, Bachmann N, et al. Germline mutations of the MSR1 gene in prostate cancer families from Germany. Hum Mutat. 2006;27(1):98-102. (Pubitemid 43042971)
36. Wang L, McDonnell SK, Cunningham JM, et al. No association of germline alteration of MSR1 with prostate cancer risk. Nat Genet. 2003;35(2):128-129. (Pubitemid 37187630)
37. Pakakasama S, Tomlinson GE. Genetic predisposition and screening in pediatric cancer. Pediatr Clin North Am. 2002;49(6):1393-1413. (Pubitemid 36160103)
38. Sugar LM. Inflammation and prostate cancer. Can J Urol. 2006;13(Suppl 1):46-47.
39. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006;124(2):263-266. (Pubitemid 43121975)
40. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66(2):605-612. (Pubitemid 43165918)
41. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6(1):24-37. (Pubitemid 43053650)
42. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-867. (Pubitemid 36019639)
43. Nakou M, Bertsias G, Stagakis I, et al. Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus. PLoS One. 2010;5(10):e13351.
44. Reid BJ, Sanchez CA, Blount PL, Levine DS. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology. 1993;105(1):119-129. (Pubitemid 23234027)
45. von Holzen U, Chen T, Boquoi A, et al. Evidence for DNA damage checkpoint activation in barrett esophagus. Transl Oncol. 2010;3(1):33-42.
46. Arber N, Lightdale C, Rotterdam H, et al. Increased expression of the cyclin D1 gene in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 1996;5(6):457-459. (Pubitemid 26182660)
47. Osterheld MC, Bian YS, Bosman FT, Benhattar J, Fontolliet C. Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus. Am J Clin Pathol. 2002;117(3):451-456. (Pubitemid 34226082)
48. Mueller A, Odze R, Jenkins TD, et al. A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities. Cancer Res. 1997;57(24):5542-5549. (Pubitemid 28006762)
49. Opitz OG, Harada H, Suliman Y, et al. A mouse model of human oral-esophageal cancer. J Clin Invest. 2002;110(6):761-769.
50. Kimchi ET, Posner MC, Park JO, et al. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res. 2005;65(8):3146-3154. (Pubitemid 40524595)
51. Jung DJ, Sung HS, Goo YW, et al. Novel transcription coactivator complex containing activating signal cointegrator 1. Mol Cell Biol. 2002;22(14):5203- 5211.
52. Lee YS, Kim HJ, Lee HJ, et al. Activating signal cointegrator 1 is highly expressed in murine testicular Leydig cells and enhances the ligand-dependent transactivation of androgen receptor. Biol Reprod. 2002;67(5):1580-1587. (Pubitemid 35204935)
53. Durmus T, LeClair RJ, Park KS, Terzic A, Yoon JK, Lindner V. Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1). Gene Expr Patterns. 2006;6(8):935-940. (Pubitemid 44309445)